4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-22-028757
SVP, Chief Medical Officer sold 36,000 shares at $1.73 ($62,280)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Attar Eyal C. SVP, Chief Medical Officer | 2022-02-28 | Sale | −36,000 | $1.73 | $62,280 | 47,000 | D |
| Open-market sales · 36,000 sh · avg $1.73 · $62,280 | |||||||
Loading xslF345X03/tm227953-1_4seq1.xml…